Earnings Call · Q4 FY2023·2024-03-06

Q4 23EPS -28.57%·Rev n/aQ3 23EPS +72.73%·Rev n/aQ2 23EPS +16.67%·Rev n/aQ1 23EPS +36.84%·Rev n/a⚠ consensus missing

Aquestive Therapeutics, Inc. AQST

Bennett Watson — Host/Moderator

Dan Barber — Chief Executive Officer

Ernie Toth — Chief Financial Officer

+20.0%1d on move date+19.5% vs SPY3d+16.5%5d+21.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AQST calls or request research access.

More AQST calls Browse calls Request research access